Regional glucose utilization in infarcted and remote myocardium its relation to coronary anatomy and perfusion

Nuclear Medicine Communications

Volumn 19, Issue 7, 1998, Pages 625-632

  Fragasso, G ^a   Chierchia, S L ^a   Landoni, C ^a   Lucignani, G ^a   Rossetti, E ^a   Sciammarella, M ^a   Vanoli, G E ^a   Fazio, F ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ANATOMY; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY BLOOD FLOW; DRUG UPTAKE; EXERCISE TEST; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; HEART INFARCTION; HEART MUSCLE METABOLISM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0031821053     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1080/00006231-199807000-00003     Document Type: Article

References (45)

1. Liedtke JA. Alterations of carbohydrate and lipid metabolism in the acutely ischemic heart. Progr Cardiovasc Dis 1981; 23: 321-336.
2. Sokoloff L, Reivich M, Kennedy C et al. The (14C) deoxy-glucose method for the measurement of local cerebral glucose utilization: Theory, procedure and normal values in the conscious and anesthetized albino rat. J Neurochem 1977; 28: 867-916.
3. Krivokapich J, Huang SC, Phelps ME, Barrio JR. Estimation of rabbit myocardial metabolic rate for glucose using fluorodeoxyglucose. Am J Physiol 1982; 243: H884-H895.
4. Gallagher BM, Anyari A, Atkins H et al. 18F-labeled 2-deoxy-2-fluoro-D-glucose as a radiopharmaceutical for measuring regional myocardial glucose metabolism in vivo: Tissue distribution and imaging studies in animals. J Nucl Med 1977; 18: 990-996.
5. Gallagher BM, Fowler JS, Gutterson NI, McGregor RR, Wan CN, Wolf AP. Metabolic trapping as a principle of radiopharmaceutical design: Some factors responsible for the biodistribution of 18-F 2-deoxy-2-fluoro-D-glucose. J Nucl Med 1978; 19: 1154-1161.
6. Ratib O, Phelps ME, Huang SC, Henze E, Selin C, Schelbert HR. Positron tomography with deoxyglucose for estimating local myocardial glucose metabolism. J Nud Med 1982; 23: 577-586.
7. Tillish J, Brunken R, Marshall R et al. Reversibility of cardiac wall motion abnormalities predicted by positron tomography. N Engl J Med 1986; 313: 884-888.
8. Schwaiger M. Metabolism and blood flow as new markers of myocardial viability in the evolution of myocardial infarction. Eur J Med 1986; 12: 562-565.
9. Schwaiger M, Brunke R, Grover McKay M et al. Regional myocardial metabolism in patients with acute myocardial infarction assessed by positron emission tomography. J Am Coll Cardiol 1986; 8: 800-808.
10. Brunken R, Tillish J, Schwaiger M. et al. Regional perfusion, glucose metabolism and wall motion in patients with chronic electrocardiographic Q wave infarctions: Evidence for persistence of viable tissue in some infarct regions by positron emission tomography. Circulation 1986; 73: 951-963.
11. Hashimoto T, Kambara H, Fudo T et al. Non Q-wave versus Q-wave myocardial infarction: Regional myocardial metabolism and blood flow assessed by position emission tomography. J Am Coll Cardiol 1988; 12: 88-93.
12. Fudo T, Kambara H, Hashimoto T et al. F-18 deoxyglucose and stress N-13 ammonia positron emission tomography in anterior wall healed myocardial infarction. Am J Cardiol 1988; 61: 1191-1197.
13. Lucignani G, Paolini G, Landoni C et al. Presurgical identification of hibernating myocardium by combined use of technetium-99m hexakis 2-methoxyisobutyl-isonitrile single photon emission tomography and fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography in patients with coronary artery disease. Eur J Nucl Med 1992; 19: 874-881.
14. Fragasso G, Chierchia SL, Lucignani G et al. Time dependence of residual tissue viability after myocardial infarction assessed by [18F] fluorodeoxyglucose and positron emission tomography. Am J Cardiol 1993; 72: 131G-139G.
15. Fragasso G, Chierchia SL, Rossetti E et al. Myocardial viability assessed with fluorodeoxyglucose and PET in patients with Q wave myocardial infarction receiving thrombolysis: Relationship to coronary anatomy and ventricular function. Nud Med Commun 1997; 18: 191-199.
16. Camici P, Araujo LI, Spinks T et al. Increased uptake of 18F-fluorodeoxyglucose in postischemic myocardium of patients with exercise-induced angina. Circulation 1986; 74: 81-88.
17. Araujo LI, Camici P, Spinks TJ, Jones T, Maseri A. Abnormalities in myocardial metabolism in patients with unstable angina as assessed by positron emission tomography. Cardiovasc Drugs Therapy 1988; 2: 47-60.
18. Austen WG, Edwards JE, Frye RL et al. A reporting system on patients evaluated for coronary artery disease (AHA Committee Report). Circulation 1975; 51: 5-29.
19. Cohen M, Rentrop KP. Limitation of myocardial ischaemia by collateral circulation during sudden controlled coronary occlusion in human subjects: A prospective study. Circulation 1986; 74: 469-476.
20. Harnacher K, Coenen KP, Stocklin G. Efficient stereo-specific synthesis of non-carrier-added 2-18-F-fluoro-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 1986; 27: 235-238.
21. Rahimtoola SH. The hibernating myocardium. Am Heart J 1989; 117: 211-221.
22. Hearse DT, Crome R, Yellon DM, Wyse RK. Metabolic and flow correlates of myocardial ischemia. Cardiovasc Res 1983; 17: 452-458.
23. Fragasso G, Benti R, Sciammarella M et al. Symptom-limited exercise testing causes sustained diastolic dysfunction in patients with coronary disease and low effort tolerance. J Am Coll Cardiol 1991; 17: 1251-1255.
24. Schwaiger M, Schelbert HR, Ellison D et al. Sustained regional abnormalities in cardiac metabolism after transient ischemia in the chronic dog model. J Am Coll Cardiol 1985; 6: 336-347.
25. Uren NG, Crake T, Lefroy DC, De Silva R, Davies GJ, Maseri A. Reduced coronary vasodilator function in infarc-ted and normal myocardium after myocardial infarction. N Eng J Med 1994, 331: 222-227.
26. Rechavia E, De Silva R, Nihoyannopoulos P, Lammertsma AA, Jones T, Maseri A. Hyperdynamic performance of remote myocardium in acute infarction: Correlation between regional contractile function and myocardial perfusion. Eur Heart J 1995; 16: 1845-1850.
27. Feldman RL, MacDonald RG, Nichols WW, Conti RC, Pepine CJ. Effects of acute coronary occlusion on hemodynamics in an adjacent coronary artery in dogs. Am J Cardiol 1984; 54: 1103-1107.
28. Lavy MN, Frank F. Vasomotor responses to acute coronary occlusion in the dog. Am J Physiol 1953; 172: 427-436.
29. Brown AM. Excitation of afferent cardiac sympathetic nerve fibres during myocardial ischemia. J Physiol (Lond) 1967; 190: 35-53.
30. Malliani A, Schwartz PJ, Zanchetti A. A sympathetic reflex elicited by experimental coronary occlusion. Am J Physiol 1969; 217: 703-709.
31. Corday E, Kaplan L, Merrbaum JS et al. Consequences of coronary arterial occlusion on remote myocardium: Effects of occlusion and reperfusion. Am J Cardiol 1975; 36: 385-394.
32. Vikhert AM, Cherpachenko NM. Changes in metabolism of undamaged sections of myocardium following infarction. Circ Res 1974; 34-35(3): 182-191.
33. Buda AJ, Lefkowitz CA, Gallagher KP. Augmentation of regional function in nonischemic myocardium during coronary occlusion measured with two-dimensional echocardiography. J Am Coll Cardiol 1990; 16: 175-180.
34. Jaarsma W, Visser CA, Eenige Van MJ et al. Prognostic implications of regional hyperkinesia and remote asynergy of non-infarcted myocardium. Am J Cardiol 1986; 58: 394-398.
35. Liedtke JA, Nellis SH, Whiteshell LF. Effects of regional ischaemia on metabolic function in adjacent aerobic myocardium. J Mol Cell Cardiol 1982; 14: 195-205.
36. Me Alpine HM, Morton JJ, Leckie B, Rumley A, Gillen G, Dargie HJ. Neuroendocrine activation after acute myocardial infarction. Br Heart J 1988; 60: 117-124.
37. Karlsberg RP, Cyrer PE, Roberts R. Serial plasma catecholamine response early in the course of clinical acute myocardial infarction: Relationship to infarct extent and mortality. Am Heart J 1981; 102: 24-29.
38. Heusch G. Alpha adrenergic mechanisms in myocardial ischemia. Circulation 1990; 81: 1-13.
39. Marcus ML, Koyanagi S, Harrison DG, Doty DB, Hiratzka LF, Eastham CL. Abnormalities in the coronary circulation that occur as a consequence of cardiac hypertrophy. Am J Med 1983; 26: 62-66.
40. Folkow B. Structural factor’ in primary and secondary hypertension. Hypertension 1990; 16: 89-101.
41. Zeiher AM, Drexler H, Wollschlaeger H, Just H. Modulation of coronary vasomotor tone in humans: Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 1991; 83: 391-401.
42. Kuo L, Davis MJ, Cannon S, Chilian WM. Pathophysiological consequences of atherosclerosis extend into the coronary microcirculation: Restoration of endothelium-dependent responses by L-arginine. Circ Res 1992; 70: 465-476.
43. Gropler RJ, Siegel BA, Lee KJ et al. Nonuniformity in myocardial accumulation of fluorine-18-fluoro-deoxyglucose in normal fasted humans. J Nucl Med 1990; 31: 1749-1756.
44. Nguyen Van TB, Mossberg KA, Tewson TJ et al. Temporal analysis of myocardial glucose metabolism by 2-18F-fluoro-2-deoxy-D-glucose. Am J Physiol 1990; 259 (28): H1022-1031.
45. Fragasso G, Lucignani G, Fazio F. Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans (letter). J Nucl Med 1991; 32: 1831-1832.